ezetrol 10 mg tabletes
merck sharp & dohme latvija, sia, latvija - ezetimibs - tabletes - 10 mg
aripiprazole teva 15 mg mutē disperģējamās tabletes
teva b.v., netherlands - aripiprazols - mutē disperģējamās tabletes - 15 mg
aripiprazole mylan 10 mg tabletes
mylan s.a.s, france - aripiprazols - tablete - 10 mg
ezetimibe pharmaswiss 10 mg tabletes
pharmaswiss ceska republika s.r.o., czech republic - ezetimibs - tablete - 10 mg
arisppa 20 mg tabletes
krka, d.d., novo mesto, slovenia - aripiprazols - tablete - 20 mg
aripiprazole mylan 15 mg tabletes
mylan s.a.s, france - aripiprazols - tablete - 15 mg
aripiprazole teva 10 mg tabletes
teva b.v., netherlands - aripiprazols - tabletes - 10 mg
bosentan sandoz 125 mg apvalkotās tabletes
sandoz d.d., slovenia - bosentāns - apvalkotās tabletes - 125 mg
poteligeo
kyowa kirin holdings b.v. - mogamulizumab - sezary syndrome; mycosis fungoides - antineoplastiski līdzekļi - poteligeo ir norādīts ārstēšanai pieaugušiem pacientiem ar mycosis fungoides (mf) vai sézary sindroms (ss), kuri ir saņēmuši vismaz vienu pirms sistēmiskā terapija.
adakveo
novartis europharm limited - crizanlizumab - anēmija, sirpjveida šūna - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.